Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cooper

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1978
Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharidesN R Cooper, D C Morrison
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1976
Activation of C1r by proteolytic cleavageR J Ziccardi, N R Cooper
Immunology|February 1, 1989
Suppression of monocyte functions by human cytomegalovirusN A Buchmeier, N R Cooper
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1994
T cell-dependent, B cell-activating properties of antibody-coated small latex beads. A new model for B cell activationA T Luxembourg, N R Cooper
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1976
Physicochemical and functional characterization of the C1r subunit of the first complement componentR J Ziccardi, N R Cooper
Virology|January 15, 1984
Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization processG R Nemerow, N R Cooper
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonistsG R Nemerow, N R Cooper
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complementG R Nemerow, N R Cooper
The Journal of Investigative Dermatology|July 1, 1985
Complement effector mechanisms in health and diseaseN R Cooper, G R Nemerow
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
CR2 ligands modulate human B cell activationJ F Bohnsack, N R Cooper
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1978
Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharidesN R Cooper, D C Morrison
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1976
Activation of C1r by proteolytic cleavageR J Ziccardi, N R Cooper
Immunology|February 1, 1989
Suppression of monocyte functions by human cytomegalovirusN A Buchmeier, N R Cooper
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1994
T cell-dependent, B cell-activating properties of antibody-coated small latex beads. A new model for B cell activationA T Luxembourg, N R Cooper
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1976
Physicochemical and functional characterization of the C1r subunit of the first complement componentR J Ziccardi, N R Cooper
Virology|January 15, 1984
Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization processG R Nemerow, N R Cooper
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonistsG R Nemerow, N R Cooper
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complementG R Nemerow, N R Cooper
The Journal of Investigative Dermatology|July 1, 1985
Complement effector mechanisms in health and diseaseN R Cooper, G R Nemerow
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
CR2 ligands modulate human B cell activationJ F Bohnsack, N R Cooper
Pageof 18